FDA refuses to review Moderna’s mRNA flu vaccine – Ars Technica
But in a letter dated February 3, Vinay Prasad, the FDA’s top vaccine regulator under the Trump administration, informed Moderna that the agency does not consider the trial “adequate and well-controlled” because the comparator vaccine “does not reflect the best-available standard of care.” In its news release, Moderna noted that neither the FDA’s regulation nor…
